Industry Outlook: Healthcare & Life Sciences — Week of May 18, 2026

Market Outlook

• Epic, InterSystems deepen payer–provider automation. InterSystems is enabling automated bi-directional data exchange between the Epic Payer Platform and health plan workflows, effectively hard-wiring clinical data into payer operations like prior auth and utilization management. This accelerates the shift from batch, clearinghouse-driven exchanges to near-real-time, API-based interoperability where FHIR and CDS hooks can be embedded directly into payer and provider systems.
• Electronic prior auth gains real early adopters. CMS announced a new wave of early adopters across payers and providers committing to electronic prior authorization, while surveys show only a third of physicians believe current payer commitments will materially reduce burden. This signals an inflection point where technical rails (APIs, FHIR, X12 modernization) are maturing faster than clinician trust, putting pressure on CTOs to deliver tangible workflow relief, not just compliance.
• EHR replacement market cools as Epic consolidates. KLAS reports a 40% drop in hospitals affected by EHR purchase decisions versus 2024, even as Epic continues to gain share, especially among smaller systems. The slowdown implies fewer rip-and-replace opportunities for vendors but a growing imperative to innovate on top of entrenched platforms via APIs, app marketplaces, and data-layer strategies rather than core EHR swaps.

Discussion: Watch capital shifting from core EHR changeouts toward surrounding AI, automation, and interoperability layers that plug into Epic and other incumbents. Roadmaps that assume replacing the core record are losing ground to strategies that embrace and extend existing EHR ecosystems.

Headwinds

• Physician skepticism on prior auth reforms persists. Only 33% of physicians believe health plans’ prior authorization pledges will make a real difference, despite CMS highlighting new ePA early adopters. If tech-led solutions are perceived as reinforcing payer control rather than eliminating low-value work, AI and automation initiatives risk backlash and underutilization.
• Regulatory scrutiny tightens across fraud and safety. CMS has halted new Medicare enrollment for hospice and home health providers amid a fraud crackdown, and the FDA has placed a clinical hold on Aardvark Therapeutics’ metabolic drug program. For digital health and TechBio players, this reinforces that aggressive growth or novel mechanisms without robust evidence, controls, and monitoring can trigger abrupt regulatory brakes that disrupt business models.
• SaaS ‘meltdown’ pressures fragmented health IT stacks. Commentary on a broader SaaS shakeout suggests many point solutions will not survive to 2027, implying vendor failures, forced consolidations, and renegotiations. Health systems and life sciences firms over-indexed on niche SaaS for workflow slices (documentation, scheduling, niche analytics) face rising integration debt and business continuity risk if vendors falter.

Discussion: Defensively, stress-test dependencies on small SaaS vendors, ensure exit paths and data portability, and design prior auth and clinical AI programs with clear, measurable burden reduction to maintain clinician and regulator trust.

Tailwinds

• AI-augmented care becoming a patient expectation. Industry leaders are signaling that patients will soon expect AI-enabled care as a standard, not a novelty, particularly for navigation, triage, and documentation support. Rural systems like Berkshire Health are already piloting targeted AI to address staffing strain and rising demand, creating reference architectures for safe, incremental deployment.
• Specialized AI stacks emerge across payer and provider. IKS Health’s acquisition of ARAI to build a specialized AI stack and Anomaly’s $17M raise for an AI-powered payer intelligence platform underscore a move from generic LLM tools to domain-specific, workflow-embedded AI. These platforms promise measurable gains in revenue cycle, coding, and fraud detection, and will increasingly expect clean FHIR data and event streams from core systems.
• New automation targets infection control and workforce gaps. Shyld AI’s $13M for autonomous room disinfection and Chromie Health’s AI-driven staffing tool (already filling tens of thousands of nursing shifts) show AI expanding into operational domains beyond clinical decision support. These use cases offer quick ROI, lower clinical risk, and can serve as ‘starter’ AI projects to build organizational confidence and data infrastructure.

Discussion: To capitalize, prioritize AI pilots with clear ROI in operations and revenue cycle, and invest in the data pipelines and governance needed for specialized AI vendors to plug into your environment cleanly and securely.

Tech Implications

• Interoperability shifts from messaging to real-time APIs. The InterSystems–Epic payer integration and CMS ePA push both lean on more automated, bi-directional data exchange, moving away from static HL7 v2 and batch X12 transactions. Architectures must increasingly expose normalized clinical and claims data via FHIR APIs, event streams, and rules engines capable of supporting prior auth, coverage checks, and care management in near real time.
• Private, on-prem and ‘in-hospital’ AI for PHI. New guidance on private voice AI emphasizes capturing clinician–patient conversations without letting PHI leave the building, reflecting a broader pattern of health systems preferring in-tenant or on-prem AI for sensitive workloads. This implies investment in GPU-capable infrastructure, container orchestration, and MLOps tooling that can host models locally while still integrating with cloud-based services where appropriate.
• Platform-first strategy amid SaaS consolidation. With a predicted SaaS shakeout by 2027, CTOs can no longer treat each point solution as a black box; instead, they need a platform strategy centered on a unified data layer, identity, and workflow orchestration. Designing around EHR platforms, FHIR data hubs, and low-code workflow engines will allow replacement of failing SaaS components with minimal disruption.

Discussion: Engineering teams should prioritize FHIR-first integration patterns, event-driven architectures, and an internal AI platform (data, model hosting, governance) that can support both commercial models and in-house tools while keeping PHI under strict control.

CTO Action Items

This week, prioritize a review of your interoperability roadmap in light of accelerating ePA and payer–provider automation: confirm you have a concrete plan for FHIR-based prior auth, coverage, and clinical data exchange that goes beyond minimum regulatory compliance. Run a SaaS dependency and resilience assessment, identifying critical clinical and operational workflows that hinge on small or single-point vendors, and define data export, substitution, and business continuity plans. On AI, select 1–2 low-risk, high-ROI operational pilots (e.g., documentation, staffing optimization, infection control) and pair them with an explicit governance and privacy model, favoring private or in-tenant deployments for PHI-heavy use cases. Finally, begin converging around a platform architecture—anchored on your EHR and a shared data layer—that can host specialized AI stacks and workflow apps without fragmenting identity, security, and observability.